Arena Pharmaceuticals Inc EBITDA
What is the EBITDA of Arena Pharmaceuticals Inc?
The EBITDA of Arena Pharmaceuticals Inc is -$548.37
What is the definition of EBITDA?
EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
ttm (trailing twelve months)
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA of companies in the Health Care sector on NASDAQ compared to Arena Pharmaceuticals Inc
What does Arena Pharmaceuticals Inc do?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Companies with ebitda similar to Arena Pharmaceuticals Inc
- HMT has EBITDA of -₨556.25
- Gracell Biotechnologies has EBITDA of -¥552.58
- Canoo has EBITDA of -$552.49
- Orphazyme A/S has EBITDA of -kr551.27
- Nitco has EBITDA of -₨550.51
- Asia Standard International has EBITDA of -HKD$549.02
- Arena Pharmaceuticals Inc has EBITDA of -$548.37
- Honghua has EBITDA of -¥545.15
- Reliance Communications has EBITDA of -₨545.00
- Naspers has EBITDA of -$536.00
- Radha Madhav has EBITDA of -₨535.49
- Hertz Global has EBITDA of -$535.00
- Hertz Global has EBITDA of -$535.00